ELION THERAPEUTICS
Live / Registered — Registered (as of 15 Apr 2025)
What this means for you
Registered since 15 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98301402
- Registration number
- 7757756
- Mark type
- Stylized text
- Filed
- 06 Dec 2023
- Published for opposition
- 25 Feb 2025
- Registered
- 15 Apr 2025
- Attorney of record
- J. Dickson Phillips III
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease
Owner
- ELION THERAPEUTICS, INC., NEW YORK, NY, US
- ELION THERAPEUTICS, INC., NEW YORK, NY, US
- ELION THERAPEUTICS, INC., NEW YORK, NY, US
- Sfunga Therapeutics, Inc., New York, NY, US
Prosecution history
- 15 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 25 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2025 — PUBLISHED FOR OPPOSITION
- 19 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Sept 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 03 Sept 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Jul 2024 — NON-FINAL ACTION E-MAILED
- 05 Jul 2024 — NON-FINAL ACTION WRITTEN
- 05 Jul 2024 — USE AMENDMENT ACCEPTED